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Abstract: We have explored the added value of interferon-γ (IFNγ)–
inducible protein 10 as a read-out of Mycobacterium tuberculosis–specific 
immunity in young Indian children, where the sensitivity of the IFNγ 
release assays for tuberculosis is poor. Reduced frequency of indeterminate 
results and an increased sensitivity for tuberculosis suggest a potential for 
fewer missed cases with a combined IFNγ/inducible protein 10 read-out in 
a 4th generation IFNγ release assays.
Key Words: tuberculosis, child, tuberculin skin test, interferon-γ release 
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(Pediatr Infect Dis J 2016;35:1336–1338)
The interferon-γ (IFNγ) release assays (IGRAs) are current state-of-the-art tests for M. tuberculosis (MTB) infection but 
have low sensitivity in young children.1 The IFNγ-inducible protein 
10 (IP-10) has emerged as an alternative read-out to increase the 
sensitivity of the IGRAs without compromising specificity. IP-10 
is expressed by antigen presenting cells and can be considered a 
downstream marker of IFNγ—the standard read-out of cell-medi-
ated immunity. The advantage of IP-10 is that it is expressed at 
higher levels than IFNγ while retaining the signal-to-noise ratio,2 
and the stability of the protein in dried blood spots implies a poten-
tial for a point-of-care diagnostic test.3
IGRAs are acknowledged supplements in diagnosis when 
tuberculosis (TB) is suspected in children but remains uncon-
firmed by smear/culture,4 as a positive test provides evidence of 
recent MTB infection. In a cohort of Indian children aged <3 years 
referred on suspicion of TB, the QuantiFERON® Gold In-Tube 
(QFT) assay, showed low sensitivity for clinical TB (23%).5 Obvi-
ously, a negative QFT is unsuited to rule out MTB infection in this 
population. The increase in indeterminate QFT tests with decreas-
ing age is also a concern.2,5 We, therefore, wanted to explore the 
possibility of increased sensitivity for the IP-10 read-out compared 
with IFNγ in this population. As indeterminate test results are 
related to mitogen response, we compared IP-10 and IFNγ con-
centrations in response to TB-specific antigens and mitogen. The 
problem in evaluating these read-outs is the lack of a gold standard 
for MTB infection. The stringent categorization of MTB-infection 
status based on the results from the Tuberculin skin test (TST) and 
QFT recently proposed by Tebruegge et al6 was, therefore, applied. 
We evaluated single versus duplex analyses of the analytes before 
choosing a multiplex analysis platform because some have sug-
gested to include both IFNγ and IP-10 as read-outs of cell-mediated 
immunity in order to increase the sensitivity.2
MATERIALS AND METHODS
As part of a prospective cohort study of 4382 neonates in 
South India, 746 children were evaluated for TB after referral based 
on predefined criteria.5
For this substudy, MTB-infection status was categorized 
according to Tebruegge et al.6 Of the 746 children, all children 
having an assignment of active clinical TB (ATB; n=13) and MTB 
infection (TST ≥10 mm and QFT positive; n=18), common dis-
cordance (TST ≥10 mm and QFT negative; n=53), and reverse dis-
cordance (TST <10 mm and QFT positive; n=19) were included, 
whereas children classified as possible discordance (TST 5–9 mm 
and QFT negative; n=22) as well as probably MTB uninfected 
(TST 1–4 mm and QFT negative; n=24) and uninfected (TST 0 and 
QFT negative; n=7) were randomly selected from the larger popula-
tion of study children with available samples.
IFNγ and IP-10 were analyzed in QFT supernatants from the 
TB antigen and mitogen tube. We applied a customized 2-plex (IFNγ 
and IP-10) cytokine/chemokine kit (Bio-Rad Laboratories Inc., 
Berkeley, CA), according to the manufacturer’s instructions. For the 
duplex assay, the optimal dilution of the QFT supernatants was 1:4. 
The difference in measured concentrations of the analytes between 
single and duplex assays was assessed by a pilot study (n=16), where 
a head-to-head comparison of paired samples (Wilcoxon Signed 
Rank test), revealed equal or better detection of the analytes on the 
more cost-effective duplex platform (Fig. 1A and B).
Clinical characteristics were summarized for children within 
the defined categories of MTB infection. IFNγ and IP-10 concentra-
tion levels and their fold change were compared between the follow-
ing MTB-infection categories (Mann–Whitney U test): ATB, MTB 
infected, common discordance, and unlikely MTB infected (probably 
MTB uninfected and uninfected clubbed). Area under curve (AUC) 
was calculated to evaluate sensitivity and specificity. A P value <0.05 
was considered significant. SPSS software version 23 and GraphPad 
Prism 5 were used for statistical analyses and figures.
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FIGURE 1. Comparison of the concentration of IFNγ and IP10 in 2-plex and single-plex set-ups in response to A: Mitogen 
and B: TB-antigen. The concentration of the analytes within the MTB infection categories in response to tuberculosis (TB) 
antigen [C: interferon-γ (IFNγ) and D: IFNγ-inducible protein 10 (IP-10)] and mitogen (H: IFNγ and I: IP-10). IP-10:IFNγ 
ratio for the MTB infection categories are depicted in response to TB antigen (E) and mitogen (J). Discriminatory capacity 
between children with active TB versus MTB infection is shown for IFNγ (F) and IP-10 (G) concentrations, respectively. The 
P values <0.05 (*), <0.01 (**), <0.001 (***) were considered to be significant. AUC indicates area under curve; ROC, receiver 
operating characteristic. 
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and the Ministry of Health Screening Committee of the Govern-
ment of India (No. 5/8/9/60/2006-ECD-I).
RESULTS
The 156 included children had a median age of 23 months, 
and 92 (60%) were male. As many as 102 (65.4%) had failure 
to thrive, and 57 (36.5%) had evidence of chronic malnutrition 
(height-for-age Z score <2). Overall, 11 (7%) children had known 
TB exposure, whereas the proportion in ATB- and MTB-infected 
children was 39 and 7.7%, respectively. Longstanding (≥2 weeks) 
cough was present in 18 (11.5%), most frequently in ATB children 
(31%), and fever was present in 10 (6.4%), most frequently in ATB 
children (31%) and reverse discordance (16%; Table, Supplemental 
Digital Content 1, http://links.lww.com/INF/C533).
The concentration of IFNγ in response to TB antigen was 
significantly higher in MTB-infected children compared with all 
other groups. As expected from the poor sensitivity of QFT in ATB 
children, no difference was observed compared with common dis-
cordance or unlikely MTB-infected children (Fig. 1C). The ability 
of IFNγ to discriminate between ATB- and MTB-infected children 
gave an AUC of 0.71 [sensitivity: 76.9% (46.2–94.9%) and speci-
ficity: 72.2% (46.5–90.3%); Fig. 1F]. No difference in the concen-
tration of IP-10 in response to TB antigen was observed between 
ATB- and MTB-infected children, but both the groups had signifi-
cantly higher IP-10 levels than the children with common discord-
ance (Fig. 1D). The ability of IP-10 to discriminate between ATB- 
and MTB-infected children was somewhat lower than that of IFNγ; 
AUC 0.65 [sensitivity: 66.7% (41.0–86.7%) and specificity 76.9% 
(46.2–95.0%); Fig. 1G].
The concentration of IFNγ in response to mitogen was sig-
nificantly lower in ATB children compared with MTB-infected 
and unlikely MTB-infected children, but this was not observed for 
IP-10. MTB-infected children had higher levels of both analytes 
than did children with common discordance (Fig. 1G and H).2
The IP-10:IFNγ ratio was significantly higher in ATB com-
pared with MTB-infected children both in response to TB antigen 
and mitogen. Interestingly, the ratio was significantly lower in MTB 
infected children compared with all other groups.
DISCUSSION
Whereas Tebruegge et al,6 analyzed IFNγ in undiluted 
supernatants and IP-10 in 1:20 diluted samples, we found that 
IFNγ and IP-10 could be analyzed on a duplex platform using a 
1:4 dilution of the QFT supernatants despite IP-10 being secreted 
at higher magnitudes. The possibility of analyzing both analytes in 
1 tube by the same assay provides simplification and cost-reduc-
tion. In line with other studies, our study provides no evidence 
for increased discrimination between ATB and MTB infection by 
IP-10 alone.2 Our study supports a higher sensitivity for the detec-
tion of ATB by TB antigen–induced IP-10 compared with IFNγ 
as the concentrations were significantly higher compared with 
children with common discordance. A recent study in a similar 
African population contradicts this finding, but IFNγ and IP-10 
were analyzed in separate enzyme-linked immunosorbent assays 
(ELISAs).7 But maybe more noteworthy when considering a com-
bined IFNγ/IP-10 read-out in a 4th IGRAs2 is the finding of a 
more compromised IFNγ than IP-10 response to mitogen in ATB 
children who had an increased IP-10:IFNγ ratio compared with 
all other groups. The pattern of blunted immune responses with 
increasing disease severity8,9 may be part of the picture. Combined, 
these findings suggest that a reduced frequency of indeterminate 
results and an increased discrimination between ATB and common 
discordance in children could be achieved by a combined IFNγ/
IP-10 read-out.
MTB-infected children seem to have the most robust overall 
immune responses in our population. It should be noted that the 
robustness of responses in MTB-infected children may be the result 
of a selection bias as the groups where, in part, defined by the QFT 
result.
Currently, IGRAs and TST are used as indicative tests in the 
diagnosis of TB in infants but cannot be used as “rule-out tests”. 
Our data suggest a possibility of improving the sensitivity of the 
IGRA in children particularly vulnerable to TB, which implies 
a potential to identify TB cases that might otherwise have been 
missed.
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